Drug Profile
Estradiol transdermal (FemPatch) - Ortho-McNeil
Alternative Names: FemPatchLatest Information Update: 19 Dec 2021
Price :
$50
*
At a glance
- Originator Ortho-McNeil
- Class Antineoplastics; Estradiol congeners; Estrenes; Hormonal replacements; Small molecules
- Mechanism of Action Estrogen receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Market Withdrawal Menopausal syndrome
Most Recent Events
- 03 Dec 1996 Registered for Menopausal syndrome in USA (Transdermal)